K.A. KOREYBA^1,2

¹Kazan State Medical University, 49 Butlerov Str., Kazan, Russian Federation, 420012

²«Diabetic Foot» Center, 34/24 Maksimov Str., Kazan, Russian Federation, 420127

Koreyba K.A. ― Cand. Med. Sc., Associate Professor of the Department of General Surgery, Head of the «Diabetic Foot» Center, tel. +7-917-259-47-47, e-mail: korejba_k@mail.ru

The article describes a complex of pathogenic treatment of the diabetic foot syndrome, including conservative therapy and surgical treatment. The proposed scheme has been used since 2012 for patients with diagnosed poly-neuropathy and the degree of tissue lesions 2-3 by Wagner scale. It allowed to significantly reduce the average time of in-hospital stay and significantly reduce the amount of operative mutilation and recurrences.

Key words: diabetes mellitus, diabetic foot syndrome, infusion therapy, bioplastic material «collost», treatment of neuropathic ulcers.

REFERENCES

1. Tokmakova A.Yu. Diabetichekaya distal’naya polinevropatiya: patogenez, klinika, diagnostika, printsipy terapii. Materialy konferentsii [Diabetichekaya distal polyneuropathy: pathogenesis, clinical features, diagnosis, treatment principles. Materials of the conference]. Moscow, 2001. Pp. 20-32.
2. Dedov I.I., Shestakova M.V., Galstyan G.R., Grigoryan O.R. et al. Algorithms specialized medical care to patients with diabetes mellitus: clinical guidelines. Sakharnyy diabet, 2015, vol. 18, no. 1S (special issue), pp. 1-112 (in Russ.).
3. Zaytseva E.L., Doronina L.P., Molchkov R.V., Voronkova I.A. et al. Influence of negative pressure therapy on reparative processes in the soft tissues of the lower extremities in patients with neuropathic and neuroischemic forms of diabetic foot syndrome. Sakharnyy diabet, 2014, no. 3, pp. 113-121 (in Russ.).
4. Tesfaye S., Chaturvedi N., Simon E.M. Vascular risk factors and diabetic neuropathy. The New England journal of medicine, 2005, vol. 352 (4), pp. 341-350.
5. Spravochnik VIDAL 2015 “Lekarstvennye preparaty v Rossii”. Izdanie 21-e, pod red. E.A. Tolmachevoy [Reference VIDAL 2015 «Drugs in Russia.» Edition 21th. Ed. by E.A. Tolmacheva], 2015. 1480 p.
6. Alejandro I., Shitta-Bey O., Bates M. et al. Target driven antibiotic therapy using peripherally inserted central catheter (PICC) lines in the management of foot infection as outpatient treatment. XII Meeting of the Diabetic Foot Study Group of the EASD. Bratislava, Slovakia, 2014. P. 52.
7. Koreyba K.A., Minabutdinov A.R. Bioplastic materials based on native collagen type I in the treatment of patients with diabetic foot syndrome. Khirurgiya. Zhurnal im. N.I. Pirogova, 2014, no. 10, pp. 83-87 (in Russ.).
8. Gorobeiko M., Svyrydov M. The effectiveness of ultrasound debridement for topical treatment of wounds without active infection at a critical ischemia in diabetic foot syndrome. XII Meeting of the Diabetic Foot Study Group of the EASD. Bratislava, Slovakia, 2014. P. 53.
9. Galstyan G.R., Sergeeva S.V., Ignat’eva V.I. et al. Clinical and economic assessment value of the quota for the treatment of patients with diabetic foot syndrome. Sakharnyy diabet, 2013, no. 3, pp. 71-83 (in Russ.).
10. Lavery L.A., Armstrong D.G., Wunderlich R.P. et al. Diabetic Foot Syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care, 2003, vol. 26 (5), pp. 1435-1438.
11. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA, 2005, vol. 293, pp. 217-228.